Pre-clinical and preliminary clinical studies have shown that inhibition of both 5 -reductase isozymes resulted in greater and more consistent suppression of circulating DHT than that observed with the selective inhibitor of 5 -reductase-2, finasteride 70
This matters because many DSIP products sold online are labeled as research peptides or research use only. These products may not be approved for human use and may not meet standards for purity, potency, sterility, or accurate labeling
Traditional Health Insurance Most patients use standard insurance plans such as: Blue Cross Blue Shield Aetna United Healthcare Cigna Typical Insurance Requirements To be covered, most insurance plans require: BMI 27 and higher in certain populations with an obesity-related condition (diabetes, high blood pressure, sleep apnea, etc.) BMI 3540 with an obesity-related condition (diabetes, high blood pressure, sleep apnea, etc.) BMI 40 may not require an additional condition However, meeting criteria alone is not enough
These studies concluded that the drug does not prolong breast cancer patients overall survival or slow disease progression significantly
